To the Editor: We report the occurrence of uveitis and pseudojaundicein patients with AIDS who were receiving the combination ofclarithromycin, rifabutin, and ethambutol for the treatmentof Mycobacterium avium complex bacteremia.
We are conducting a prospective, randomized, multicenter studycomparing two oral multidrug regimens for the treatment of M.avium complex bacteremia in adults with AIDS. As of November5, 1993, 119 patients had entered this study, 59 of whom wereassigned to receive a regimen consisting of 1000 mg of clarithromycintwice daily, 600 mg of rifabutin daily, and 15 mg of ethambutolper kilogram of body . . . [Full Text of this Article]
References
This article has been cited by other articles:
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J. Jr., Winthrop, K., on behalf of the ATS Mycobacterial Diseases Subcom,
(2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am. J. Respir. Crit. Care Med.
175: 367-416
[Full Text]
(2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis. Am. J. Respir. Crit. Care Med.
167: 603-662
[Full Text]
Vaudaux, J. D., Guex-Crosier, Y.
(2002). Rifabutin-induced cystoid macular oedema. J Antimicrob Chemother
49: 421-422
[Abstract][Full Text]
Silva, R. A., Pais, T. F., Appelberg, R.
(2001). Blocking the Receptor for IL-10 Improves Antimycobacterial Chemotherapy and Vaccination. J. Immunol.
167: 1535-1541
[Abstract][Full Text]
TANAKA, E., KIMOTO, T., TSUYUGUCHI, K., WATANABE, I., MATSUMOTO, H., NIIMI, A., SUZUKI, K., MURAYAMA, T., AMITANI, R., KUZE, F.
(1999). Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease. Am. J. Respir. Crit. Care Med.
160: 866-872
[Abstract][Full Text]
Hafner, R., Bethel, J., Power, M., Landry, B., Banach, M., Mole, L., Standiford, H. C., Follansbee, S., Kumar, P., Raasch, R., Cohn, D., Mushatt, D., Drusano, G.
(1998). Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers. Antimicrob. Agents Chemother.
42: 631-639
[Abstract][Full Text]
(1997). Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria. Am. J. Respir. Crit. Care Med.
156: 1-25
[Full Text]
Shafran, S. D., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, M. J., Rachlis, A. R., Lalonde, R. G., Fanning, M. M., Tsoukas, C. M., The Canadian HIV Trials Network Protocol 010 Study,
(1996). A Comparison of Two Regimens for the Treatment of Mycobacterium avium Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin. NEJM
335: 377-384
[Abstract][Full Text]
Whitcup, S. M.
(1996). Ocular Manifestations of AIDS. JAMA
275: 142-144
[Abstract]
To, K. W., Tsiaras, W. G., Thayer, W. R.
(1995). Rifabutin Use in Inflammatory Bowel Disease. Arch Ophthalmol
113: 1354-1354
[Abstract]
Levin, L. A.
(1995). Ophthalmology. JAMA
273: 1703-1705
[Abstract]
Rifai, A., Peyman, G. A., Daun, M., Wafapoor, H.
(1995). Rifabutin-Associated Uveitis During Prophylaxis for Mycobacterium avium Complex Infection. Arch Ophthalmol
113: 707-707
[Abstract]
Karbassi, M., Nikou, S.
(1995). Acute Uveitis in Patients With Acquired Immunodeficiency Syndrome Receiving Prophylactic Rifabutin. Arch Ophthalmol
113: 699-701
[Abstract]
Saran, B. R., Maguire, A. M., Nichols, C., Frank, I., Hertle, R. W., Brucker, A. J., Goldman, S., Brown, M., Van Uitert, B.
(1994). Hypopyon Uveitis in Patients With Acquired Immunodeficiency Syndrome Treated for Systemic Mycobacterium avium Complex Infection With Rifabutin. Arch Ophthalmol
112: 1159-1165
[Abstract]
Fuller, J. D., Stanfield, L. E.D., Craven, D. E.
(1994). Rifabutin Prophylaxis and Uveitis. NEJM
330: 1315-1316
[Full Text]